Nikulski Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.36M Buy
39,671
+775
+2% +$144K 2.02% 15
2025
Q1
$8.15M Sell
38,896
-81
-0.2% -$17K 2.46% 10
2024
Q4
$6.93M Buy
38,977
+1,171
+3% +$208K 2.04% 15
2024
Q3
$7.47M Buy
37,806
+264
+0.7% +$52.1K 2.23% 14
2024
Q2
$6.44M Sell
37,542
-769
-2% -$132K 2.05% 16
2024
Q1
$6.98M Sell
38,311
-383
-1% -$69.7K 2.31% 13
2023
Q4
$6M Sell
38,694
-576
-1% -$89.3K 2.2% 14
2023
Q3
$5.85M Buy
39,270
+5,651
+17% +$842K 2.42% 12
2023
Q2
$4.53M Buy
33,619
+1,079
+3% +$145K 1.87% 16
2023
Q1
$5.19M Sell
32,540
-318
-1% -$50.7K 2.29% 13
2022
Q4
$5.31M Buy
32,858
+120
+0.4% +$19.4K 2.53% 10
2022
Q3
$4.39M Buy
32,738
+100
+0.3% +$13.4K 2.27% 13
2022
Q2
$5M Sell
32,638
-75
-0.2% -$11.5K 2.48% 11
2022
Q1
$5.3M Buy
32,713
+691
+2% +$112K 2.24% 12
2021
Q4
$4.34M Buy
32,022
+1,075
+3% +$146K 1.82% 16
2021
Q3
$3.34M Buy
30,947
+663
+2% +$71.5K 1.54% 20
2021
Q2
$3.54M Sell
30,284
-554
-2% -$64.8K 1.65% 19
2021
Q1
$3.34M Sell
30,838
-378
-1% -$40.9K 1.71% 17
2020
Q4
$3.35M Buy
31,216
+1,661
+6% +$178K 1.83% 16
2020
Q3
$2.59M Buy
29,555
+487
+2% +$42.7K 1.64% 17
2020
Q2
$2.85M Buy
29,068
+582
+2% +$57.1K 2% 14
2020
Q1
$2.17M Sell
28,486
-1,804
-6% -$137K 1.89% 16
2019
Q4
$2.52M Sell
30,290
-737
-2% -$61.3K 1.82% 18
2019
Q3
$2.29M Buy
31,027
+1,118
+4% +$82.3K 1.9% 18
2019
Q2
$2.04M Sell
29,909
-3,644
-11% -$249K 1.73% 20
2019
Q1
$2.7M Sell
33,553
-2,040
-6% -$164K 2.63% 13
2018
Q4
$3.28M Sell
35,593
-796
-2% -$73.4K 3.44% 7
2018
Q3
$2.83M Buy
36,389
+5,306
+17% +$413K 2.64% 14
2018
Q2
$2.88M Buy
31,083
+506
+2% +$46.9K 2.65% 14
2018
Q1
$2.89M Buy
30,577
+1,854
+6% +$175K 2.87% 12
2017
Q4
$2.78M Buy
+28,723
New +$2.78M 3% 11